18F-Fluciclovine PET/CT Detection of Recurrent Prostate Carcinoma in Patients With Serum PSA ≤ 1 ng/mL After Definitive Primary Treatment
نویسندگان
چکیده
منابع مشابه
modern surgical techniques in treatment of patients with cleft lip & cleft palate
چکیده ندارد.
15 صفحه اولDetection of recurrent prostate cancer with 18F-fluorocholine PET/CT in relation to PSA level at the time of imaging
PURPOSE To evaluate fluorine-18 fluorocholine (FCH) PET/CT for the detection of recurrent prostate cancer in relation to prostate-specific antigen (PSA) level. METHODS FCH PET/CT was performed in 50 patients with rising PSA levels at follow-up of primary treatment of prostate cancer (radical prostatectomy in 28, radiation therapy in 13, and brachytherapy in 9). PET detection rates were determ...
متن کاملSerum PSA, Gleason Score and Clinical Staging in Predicting Biochemical (PSA) Failure After Radical Prostatectomy for Carcinoma of Prostate
Background: I t has been suggested that pre-operative serum PSA, Gleason Score of the tumour as well as stage of the tumour may predict the possibility of PSA (Biochemical) recurrence after radical prostatectomy for localized prostate cancer. Aims: To investigate and to confirm the relationship between biochemical failure rates with regard to: serum PSA levels; Gleason score of prostate biopsy ...
متن کاملAssociation of Polymorphisms in the Prostate-Specific Antigen (PSA) Gene Promoter with Serum PSA Level and PSA Changes after Dutasteride Treatment in Korean Men with Benign Prostatic Hypertrophy
PURPOSE Studies of genetic variation in the prostate-specific antigen (PSA) gene have improved the diagnostic accuracy of PSA for diagnosing prostate diseases in Caucasians. However, the reference ranges and pharmacokinetics of PSA differ significantly according to race. Therefore, we evaluated the association between genetic variations in the PSA promoter area and benign prostatic hyperplasia ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Nuclear Medicine
سال: 2019
ISSN: 1536-0229,0363-9762
DOI: 10.1097/rlu.0000000000002432